Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide (Q35710178)

9 August 2017

1 reference

title

Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide (English)

1 reference

9 August 2017

1 reference

1 reference

0 references

Tomas Maira-Litran

1

1 reference

9 August 2017

Andrea Kropec

series ordinal

2

1 reference

9 August 2017

Donald Goldmann

series ordinal

3

1 reference

9 August 2017

Gerald B Pier

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

22

1 reference

9 August 2017

7

1 reference

9 August 2017

872-879

1 reference

Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Antimicrobial resistance: the example of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Meningococcal serogroup C conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The new pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Oligosaccharide-protein conjugates as vaccine candidates against bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Structure of the type 5 capsular polysaccharide of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The repeating sequence of the capsular polysaccharide of Staphylococcus aureus M.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Staphylococcal vaccines: a realistic dream

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Proposed virulence factors among coagulase-negative staphylococci isolated from two healthy populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Correlation of Staphylococcus aureus icaADBC genotype and biofilm expression phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Staphylococcus epidermidis biofilms: importance and implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

MSCRAMM-mediated adherence of microorganisms to host tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Surface protein adhesins of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Comparative virulence of Staphylococcus epidermidis isolates in a murine catheter model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Virulence of Staphylococcus epidermidis in a mouse model: significance of extracellular slime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Phenotypic and genotypic markers of Staphylococcus epidermidis virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Polysaccharide conjugate vaccines for the prevention of gram-positive bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Hemagglutination and adherence to plastic by Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Characterization of clinically significant strains of coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.033

7 January 2021

10.1016/J.VACCINE.2003.11.033

Identifiers

DOI

1 reference

9 August 2017

1 reference